AssetMark’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
Other funds holding TECH
AssetMark's TECH Position: Q3 2026 in Review
AssetMark increased its Bio-Techne (TECH) stake by 2.8% in Q3 2026, buying an estimated $288 and bringing the position to 146 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.
AssetMark first reported a position in TECH in Q4 2016 and has held it in 16 quarters since. The position peaked at $90.5K in Q4 2025. 462 funds tracked by Wall St. Rank hold TECH as of Q3 2026.
- AssetMark held 146 shares of Bio-Techne worth $10.6K as of Q3 2026.
- AssetMark bought 4 Bio-Techne shares in Q3 2026, an estimated $288.
- Bio-Techne made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2483 holding.
- AssetMark first reported a position in Bio-Techne in Q4 2016 and has held it in 16 quarters since.
- AssetMark's Bio-Techne position peaked at $90.5K in Q4 2025.
- 462 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.